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Abstract. Cerebellar amyloid- (A) deposition in the form of neuritic plaques and Purkinje cell loss are common in certain
pedigrees of familial Alzheimer’s disease (FAD) mainly linked to PS1 mutations. AβPP/PS1 transgenic mice, here used as a
model of FAD, show a few A plaques in the molecular layer of the cerebellum at 6 months, and which increase in number with
age. Motor impairment is apparent in transgenic mice aged 12 months. Combined methods have shown degenerated parallel
fibers as the main component of dystrophic neurites of A plaques, loss of synaptic contacts between parallel fibers and dendritic
spines of Purkinje cells, and degeneration of granule cells starting at 12 months and increasing in mice 18/20 months old. In
addition, abnormal mitochondria and focal loss of Purkinje and basket cells, together with occasional axonal torpedoes and
increased collaterals of Purkinje cells in mice aged 18/20 months, is suggested to be a concomitant defect presumably related
to soluble extracellular or intracellular A. These observations demonstrate serious deterioration of the neuronal circuitry in
the cerebellum of AβPP/PS1 transgenic mice, and they provide support for the interpretation of similar alterations occurring in
certain pedigrees with FAD.
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INTRODUCTION
Alzheimer’s disease (AD) is the most common
cause of cognitive impairment and dementia in old
age. The neuropathological features of AD comprise
neuronal loss mainly in the cerebral cortex and hip-
pocampus accompanied by the presence of amyloid-
(A) plaques and neurofibrillary tangles, the two main
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histopathological hallmarks of the disease [1, 2]. The
majority of cases are sporadic (sAD), but a percent-
age of AD is triggered by dominant genetic factors
as in Down syndrome (chromosome 21 trisomy) and
in familial cases with autosomal dominant inheri-
tance (familial AD: FAD) caused by mutations in the
amyloid- protein precursor (AβPP) gene on chromo-
some 21, the presenilin-1 (PS1) gene on chromosome
14, and the presenilin-2 gene on chromosome 1 [3].
The cerebellar cortex may be involved at advanced
stages of sAD showing diffuse A deposits, but with
the absence of neurofibrillary tangles and loss of Purk-
inje cells [4–7]. Cerebellar alterations appear earlier
and are more severe in FAD, being characterized, in
addition to Purkinje cell loss, by the presence of neu-
ritic plaques [8–12]. However, little is known about
the consequences on cortical cerebellar circuitry result-
ing from cerebellar A deposition, and their possible
implications in cerebellar dysfunction in AD and, par-
ticularly, in FAD.
Double-transgenic AβPP/PS1 mice express a
chimeric mouse/human APP (Mo/HuAPP695swe:
APP Swedish mutation) and a mutant human pre-
senilin 1 (PS1-dE9), both directed to central nervous
system neurons under the mouse PRNP, prion pro-
tein promoter [13]. The included Swedish mutation
(K595N/M596L) elevates the amount of A and the
mutant PS1 allele accelerates the A deposition rate.
Transgenic mice show impaired memory and learn-
ing performance accompanied by histopathological
alterations such as A plaques in the neocortex and
cerebellum [13–16]. For these reasons, AβPP/PS1
double-transgenic mice are considered suitable models
for FAD.
The present paper is aimed at identifying alterations
in the circuitry of the cerebellar cortex that would
permit better understanding of the alterations result-
ing from cerebellar extracellular A deposition in the
impaired cerebellar function in AβPP/PS1 transgenic
mice, with implications in FAD.
MATERIALS AND METHODS
Animals
The experiments were carried out on AβPP/PS1
mice and wild-type (WT) littermates. The genera-
tion of mice expressing the human mutated forms
APPswe and PS1dE9 has already been described
[17]. Identification of transgenic mice was carried out
by PCR of genomic DNA isolated from 1 cm tail clips
as proposed by the Jackson Laboratories. Animals
were maintained under standard animal housing condi-
tions in a 12 h dark-light cycle with free access to food
and water. Experiments were carried out according
to ethical guidelines (European Communities Coun-
cil Directive 86/609/EEC) and approved by the local
ethics committee (UB-IDIBELL).
Human cases
The cerebellum of three cases bearing mutations in
PS1 with neuritic plaques [17] and four advanced sAD
cases with diffuse cerebellar plaques were examined
for immunohistochemistry in paraffin sections.
Motor function
Motor function was evaluated in mice aged 6 and 12
months (11 AβPP/PS1 mice from different litters and
8 WT littermates per age) with two different behav-
ioral paradigms: the wire hanging test and the rotarod.
For the wire-hanging test, the apparatus consisted of a
coat hanger (50 cm long; 2 mm in diameter) suspended
32 cm above a sawdust-covered surface. Latency-to-
fall was measured from the time animals were placed
hanging by their forepaws on the wire until they fell,
with a maximum time of 1 min. Three days after the
exposure to the wire hanging test, animals were placed
in the rotarod (Rotamex 4/8; Columbus Instruments,
OH, US). The apparatus consisted of a plastic roller
(3 cm in diameter) with small grooves running along
its turning axis. Mice received four trials per day for
two consecutive days. During each test session, ani-
mals were placed on the rod rotating at a constant speed
(4 rpm), and then the rod started to accelerate continu-
ously from 4 to 40 rpm over 600 s. The latency-to-fall
off the rotarod was recorded. The improvement in the
motor coordination throughout the different trials was
calculated as the difference between the latency-to-fall
in each trial with respect to the first one. A criterion of
a minimum latency-to-fall of 10 s during the last trial
was established in order to classify animals depending
on their ability to exhibit motor function in the rotarod.
Data were analyzed with Student’s t-test. χ2 analysis
was performed to compare the percentage of mice
that acquired motor coordination criteria in the rotarod
between the different experimental groups. In all the
experiments, the significance level was set at p < 0.05.
Histological procedures
Animals aged 6, 12, and 18/20 months were exam-
ined for the chronological appearance of cerebellar A
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plaques (3 AβPP/PS1 mice and 3 WT per time-point).
With this aim the number of plaques per section was
counted in 5 sections per animal.
However, further histological studies were cen-
tered in animals aged 12 months (n = 4) and 18/20
months (n = 3), and corresponding age-matched con-
trol littermates (n = 3 per time-point). AβPP/PS1 mice
and control animals were deeply anesthetized by
intraperitoneal injection (0.2 mL/10 g body weight)
with a mixture of ketamine (100 mg/kg) and xylazine
(20 mg/kg) prior to intra-cardiac perfusion with 4%
paraformaldehyde in PBS delivered at a pressure of
19 mL/min. Brains were removed and post-fixed in
the same fixative for 4 h. The cerebella were dissected
and embedded in paraffin. Ten-m-thick mid-sagittal
sections were collected on slides and used for the mor-
phometric and morphological analyses.
Morphometric analysis
The morphometric analysis was performed on
digital images of sections of cerebellar vermis
immunostained for calbindin (3 AβPP/PS1 mice and
3 WT littermates and 5 sections per animal), captured
using an Olympus camera mounted on an Olympus
BX51 microscope at 4X magnification. All images
were analyzed using the NIH ImageJ software.
The average area of cerebellar cortex in mm2 was
obtained by outlining the contour of sections. The data
were analyzed with Student’s t-test. The significance
level was set at p < 0.05.
For Purkinje cell counts, the total number of Purk-
inje cells per section was counted and the depth of the
Purkinje cell layer measured. The Purkinje cell linear
density was obtained by dividing the number of Purk-
inje cells by the depth of the layer. Statistical evaluation
of differences was performed by means of the two-level
nested ANOVA on ranks test.
Morphological analysis
Light microscopy immunohistochemistry: For
immunohistochemistry the following antibodies were
used: mouse anti-A IgG (1 : 50, Dako, DK), rabbit
anti-GFAP serum (1 : 500, Dako, DK), voltage depen-
dent anion channel (VDAC) (1 : 100, Calbiochem,
Spain), Iba1 rabbit polyclonal antibody for microglia
(1 : 250, Wako, Richmond, VA, US), rabbit anti-
calbindin serum (1 : 5,000; CB38, Swant, CH), rabbit
anti-calretinin serum (1 : 800, Chemicon, MA, US),
mouse anti-parvalbumin IgG (1 : 1,000, Sigma, MO,
US), mouse anti-neuronal pentraxin 1 IgG (1 : 100, a
generous gift of Dr. R. Trullas, Barcelona, Spain), rab-
bit anti-phospho-SAPK/JNK serum (Thr183/Tyr185;
1 : 25, Cell Signaling, MA, US), rabbit anti-phospho-
tau serum (Ser 199, and Thr 231; 1 : 100, Chemicon,
DE), rabbit anti--synuclein serum (1 : 500, Chemi-
con, DE), mouse anti-synaptophysin IgG (1 : 500,
Dako, DK), rabbit anti-ubiquitin serum (1 : 500,
Dako, DK), and rabbit anti-active-caspase-3 serum
(1 : 25, Cell Signaling, Beverly, MA, US).
Two slides per animal were used for each immunore-
action. After de-waxing, sections were boiled with
citrate buffer for 20 min to enhance antigenicity. Sec-
tions for A immunocytochemistry were pre-treated
with 98% formic acid for 3 min. The endogenous
peroxidases were blocked by incubation in 10%
methanol-1% H2O2 solution for 5 min. To block
unspecific sites, sections were incubated with 3%
normal horse serum for 1 h. Incubation with the pri-
mary antibodies was carried out at 4◦C overnight.
The immunoreaction was revealed with biotiny-
lated secondary antibodies (Dako, DK), followed
by EnVision+ system peroxidase (Dako, DK) and
3′,5′-diaminobenzidine tetrahydrochloride. Some sec-
tions were incubated only in buffer instead of primary
antibodies; no immunostaining was detected in these
sections.
In situ end-labeling of nuclear DNA fragmentation
(TUNEL) was carried out as previously reported [18]
using cerebellar sections of x-irradiated newborn rats
(2 Gy) killed 6 h after irradiation as positive controls.
The same controls were used for immunocytochem-
istry to active caspase 3.
Human cases were processed in the same way
excepting double-labeling immunohistochemistry to
A and VDAC, in which the peroxidase reaction of
A was visualized with diaminobenzidine, NH4NiSO4
and H2O2. The immunoreaction results in a blue-grey
precipitate.
Immunofluorescence and confocal microscopy: The
following antibodies were used for immunofluo-
rescence: mouse anti-A IgG (1 : 50, Dako, DK),
rabbit anti-GFAP serum (1 : 500, Dako, DK), rabbit
anti-calbindin serum (1 : 5,000; CB38, Swant, Switzer-
land), rabbit anti-calretinin serum (1 : 800, Chemicon,
Billerica, MA, US), guinea-pig anti-vesicular gluta-
mate transporter 1 (VGluT1) serum (1 : 50, Frontier
Science, JP), and mouse anti-neurofilament 200 kDa
IgG (RT97; 1 : 50, Novocastra, UK).
To block lipofuscin fluorescence, de-waxed sections
were stained with a saturated solution of Sudan black
B (Merck, DE) for 30 min. After treatment with citrate
buffer to enhance antigenicity, the sections were incu-
bated at 4◦C overnight with combinations of primary
antibodies. Sections for A immunocytochemistry
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were pre-treated with 98% formic acid for 3 min.
After washing, the sections were incubated with
the appropriate secondary antibodies conjugated with
Alexa488, Alexa546, or Alexa633 (1 : 400, Molecular
Probes, CA, US). After counterstaining of nuclei with
DRAQ5™ (1 : 2,000, Biostatus, UK), the sections were
mounted in Immuno-Fluore mounting medium (ICN
Biomedicals, CA, US), sealed, and dried overnight.
Sections were examined with a Leica TCS-SL confocal
microscope.
The quantitative estimation of co-localized antigens
was performed calculating the ‘co-localization coeffi-
cients’ on plotted cytofluorograms [19]. The data were
analyzed with Student’s t-test. The significance level
was set at p < 0.05.
Transmission electron microscopy
AβPP/PS1 and WT mice aged 12 and 18/20 months
(n = 3 per age and group) were deeply anaesthetized
and perfused with 4% paraformaldehyde and 0.1%
glutaraldehyde in PBS. Sagittal sections of cerebel-
lar vermis (1 mm thick) were post-fixed in 1% OsO4
for 2 h and embedded in Epon 812. Semithin sections
were stained with toluidine blue and ultrathin sections
with uranyl acetate and lead with citrate. Samples were
examined with a Jeol Jem 1011 electron microscope.
RESULTS
Motor function
AβPP/PS1 mice exhibited preserved motor function
at the age of 6 months but decreased motor function in
both the wire hanging and the rotarod tests at the age
of 12 months. For this reason, no further tests were
carried out on animals older than one year. In the wire-
hanging test, the fall latency of AβPP/PS1 mice was
significantly lower (−55%) than in WT mice (p < 0.05)
(Fig. 1a). In addition, AβPP/PS1 mice exhibited less
improvement in the rotarod test throughout the consec-
utive trials. However, differences between AβPP/PS1
and WT mice were not statistically significant in any
test trial (Fig. 1b). The percentage of animals that
reached the motor coordination criterion in the rotarod
after 8 trials was 75% for WT mice and 27% in the
AβPP/PS1 group, revealing a significant ability reduc-
tion in transgenic animals (p < 0.05) (Fig. 1c).
Gross changes in the cerebellum
Measurement of the mid-sagittal section area
revealed that the cerebellar vermis of AβPP/PS1 mice
Fig. 1. Behavioral testing of the motor function of AβPP/PS1 mice
in comparison with age-matched WT at 12 months. a) In the wire
hanging test, transgenic mice exhibit a significant decrease in the
latency-to-fall with respect to WT animals. b) Deterioration of motor
function in transgenic animals is manifested by reduced skills in
rotarod performance throughout eight consecutive trials. c) Latency-
to-fall of each experimental animal during the last test trial in the
rotarod. Only three of the eleven AβPP/PS1 mice reached the motor
function criterion in the rotarod (minimum latency-to-fall of 10 s,
dotted line), revealing impairment in the motor function of transgenic
mice compared to WT littermates (p < 0.05). Data are expressed as
mean ± SD. *p < 0.05, compared to WT mice (Student’s t-test).
was smaller than the cerebellum of their WT lit-
termates. A 20% reduction was found in transgenic
mice when compared with age-matched controls at
the age of 18/20 months (WT versus AβPP/PS1:
9.96 ± 0.16 mm2 versus 8.35 ± 0.33 mm2, p < 0.01).
General microscopical findings
In the cerebellum of 6-month-old AβPP/PS1 mice,
very few A deposits were observed, and these were
exclusively found in the molecular layer (ML). A
deposits were frequent in the ML in 12-month-old mice
(Fig. 2). A few A deposits were also present in the
internal granular layer immediately beneath the Purk-
inje cell layer. The number of deposits increased with
disease progression in mice aged 18/20 months, the
last time-point examined (Fig. 3A–C). A deposits
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Fig. 2. Graphic representation of single counting of A plaques
(number of plaques/section, ordinate) obtained in 5 sections per
animal, immunostained for A. The maximum value obtained for
each age-point does not overlap with the minimum value for the
subsequent age-point.
were not observed in WT mice. At early stages, A
extracellular deposits were mainly diffuse; a few neu-
ritic plaques were observed at 12 months, whereas such
neuritic plaques were predominant at the age of 18/20
months. Neuritic plaques were characterized by a cen-
tral core of A surrounded by microglia (Fig. 3D)
and astrocytes, and by dystrophic neurites clearly
visualized with antibodies to mitochondrial porin
VDAC (Fig. 3E), synaptophysin (Fig. 3F), among other
proteins.
Cotton-wool plaques as seen in FAD cases due to
PS1 mutations were not seen in AβPP/PS1 mice. Yet
A angiopathy was common, involving the meningeal
and cerebellar blood vessels (data not shown).
Extracellular Aβ deposits and glial cells
Extracellular A deposits in the cerebellum were
focal (Fig. 4a). However, astrocytes and Bergmann
glial cells throughout the ML were more reactive to
GFAP immunohistochemistry in AβPP/PS1 mice aged
18/20 months when compared with age-matched WT
animals (Fig. 4b, c). In addition, astrocyte processes,
as identified with double-labeling immunofluores-
cence to A and GFAP, and confocal microscopy,
surrounded A deposits in the ML (Fig. 4d). Further-
more, with electron microscopy, microglial cells with
dense nucleus and cytoplasm filled with lysosomes
and residual bodies were often encountered adjacent to
dystrophic neurites surrounding A plaques (Fig. 4e).
Purkinje cells
Calbindin immunohistochemistry revealed various
alterations of Purkinje cells, including the presence of
enlarged axons (Fig. 5a), axonal spheroids (Fig. 5b),
and hypertrophic infra-ganglionic plexuses (Fig. 5c).
In addition, some convolutions were devoid of Purkinje
Fig. 3. Representative images of A plaques in the cerebellum of AβPP/PS1 mice aged 12 (A) and 18/20 (B, C) months, mainly located in the
molecular layer but also in the granule cell layer. The majority of A plaques in mice aged 18/20 months are surrounded by microglia (D) and
show increased VDAC (E) and synaptophysin (F) immunoreactivity in surrounding neuronal processes characteristic of dystrophic neurites of
neuritic plaques. Paraffin sections slightly counterstained with hematoxylin.
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Fig. 4. A plaque in the molecular layer of AβPP/PS1 mice aged 18/20 months (a, arrows). Increased GFAP immunoreactivy is observed in the
molecular layer in AβPP/PS1 transgenic mice (c) when compared with age-matched littermates (b). Double-labeling immunofluorescence for
GFAP and A shows astrocytic processes (red) surrounding A plaques (green) in the molecular layer (ML) (d). Electron microscopy shows
a microglial cell (white arrow) adjacent to dystrophic neurites (PF) in the vicinity of an A plaque. The cytoplasm of the cell is filled with
lysosomes and residual bodies (d). ML = molecular layer, Pc = Purkinje cell layer, BA = A.
cells (Fig. 5d). Cell counting revealed that the linear
cell density of Purkinje cells was reduced by 18% and
25% in transgenic mice in comparison with WT ani-
mals at the age of 12 and 18/20 months, respectively
(p < 0.05 and p < 0.001, at the ages of 12 months and
18/20 months).
Electron microscopic examination of the molecular
layer revealed the presence of large mitochon-
dria in dendrites and small branches of Purkinje
cells, accompanied by occasional dark mitochon-
dria at the ages of 12 and 18/20 months (Fig. 5e).
Dendritic arbors of Purkinje cells were distorted
around the amyloid deposits, as shown by double-
labeling immunofluorescence to calbindin and A,
and confocal microscopy (Fig. 5f, g). No calbindin-
immunoreactive dystrophic processes were evidenced
with double-labeling immunofluorescence and confo-
cal microscopy.
Electron microscopy of the Purkinje cell layer
disclosed occasional Purkinje cells with shrunken
cytoplasm and dark nuclei, and increased lipofuscin
granules at the ages of 12 and 18/20 months (Fig. 5h).
Parallel fibers and granule cells
Calretinin immunohistochemistry, used as a marker
of parallel fibers, revealed dystrophic terminals around
A deposits in the ML in mice aged 18/20 months
(Fig. 6a). This was further demonstrated by double-
labeling immunofluorescence to calretinin and A and
confocal microscopy (Fig. 6b, c). Electron microscopy
revealed the dystrophic nature of these processes,
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Fig. 5. Calbindin immunohistochemistry in AβPP/PS1 mouse cerebellum aged 18/20 months shows enlarged Purkinje cell axons in the white
matter (a, arrow), axonal spheroids: torpedoes (b, arrows), and hypertrophic infra-ganglionic plexuses (c, arrow). Focal loss of Purkinje cells
and corresponding arbors (d and insert) is observed in AβPP/PS1 mice. Electron microscopy shows a branch of a Purkinje cell dendrite (e,
arrows) filled with large mitochondria and occasional electron-dense mitochondria (arrowhead) in the vicinity of dystrophic neurite (PF).
Double-labeling immunofluorescence for calbindin (red) and A (green) shows A plaques in the molecular layer, some of them displacing the
arbors of Purkinje cells, but apparently not producing dystrophic neurites (f, g). Nuclei are stained with Draq5 (blue). Electron microscopy shows
a degenerating Purkinje cell with dark nucleus and cytoplasm, and enlarged cisternae of the endoplasmic reticulum, together with increased
lipofuscin deposition (h). ML = molecular layer, Pc = Purkinje cell layer, IGL = granule cell layer, WM = white matter.
showing huge processes filled with altered mito-
chondria, and large numbers of membrane-bound
pleomorphic bodies and other debris (Fig. 6d). Since
pentraxin 1 (NP1) is part of the program of apoptotic
death in cerebellar granule neurons [20], antibodies
to NP1 were used to detect degeneration in cerebellar
dystrophic neurites. Strong NP1 immunoreactivity was
observed in dystrophic neurites of the cerebellum in
AβPP/PS1 transgenic mice (Fig. 6e).
Moreover, dystrophic cell processes surrounding
A deposits were also immunopositive with phospho-
SAPK/JNK (Fig. 6f), a stress-activated protein kinase
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Fig. 6. Calretinin immunostaining shows positive dystrophic neurites in the molecular layer surrounding A plaques in AβPP/PS1 transgenic
mice aged 18/20 months (a). Double-labeling immunofluorescence for calretinin (red) and A (green), and confocal microscopy demonstrate
the relationship between calretinin-immunoreactive dystrophic neurites and A deposits in the molecular layer (b, c). Draq5 nuclear staining
is visualized in blue. Electron microscopy shows dystrophic neurites (PF) surrounding A deposits (d). Dystrophic neurites are positive for
NP1 (e) and for phospho-SAPK/JNK (f), and they contain phospho-tau (g), -synuclein (h), synaptophysin (i), and ubiquitin (j). Degenerating
granule cells with condensed peripheral chromatin and dark cytoplasm contrast with the normal morphology of preserved neighboring granule
cells (k, l). ML = molecular layer, Pc = Purkinje cell layer, IGL = granule cell layer, BA = A, Gr = Granule cell.









Fig. 7. Loss of synaptic contacts between parallel fibers and Purkinje cells in AβPP/PS1 mouse cerebellum aged 18/20 months, as revealed with
triple-labeling immunofluorescence and confocal microscopy to calbindin (green), calretinin (red), and the VGluT1 (blue) (a–c). Dystrophic
neurites are stained with calretinin and VGluT1, demonstrating that dystrophic neurites of A plaques are parallel fibers (c, merge). Cytoflu-
orogram analysis of WT (d) and AβPP/PS1 (e) reconstructed confocal images show a significant reduction in colocalization of calbindin with
VGluT1 (−60%, f) in AβPP/PS1 mouse cerebellum. Data are expressed as mean ± SD. **p < 0.01, compared to WT mice (Student’s t-test).
ML = molecular layer, Pc = Purkinje cell layer, IGL = granule cell layer.
partly involved in protection against cerebellar granule
cell death by regulating NP1 expression [21]. Small
amounts of phospho-tau were visible around many
plaques, as revealed with different phospho-specific
anti-tau antibodies (Fig. 6g). In addition to phos-
phorylated tau, other proteins were accumulated in
dystrophic neurites surrounding A deposits, includ-
ing -synuclein (Fig. 6h), synaptophysin (Fig. 6i), and
ubiquitin (Fig. 6j).
Electron microscopic examination of the granular
layer disclosed occasional granule cells with degener-
ative features such as compacted peripheral chromatin
and electron-dense cytoplasm (Fig. 6k, l).
Caspase 3 immunoreaction failed to show posi-
tive cells in the AβPP/PS1 mice cerebellum. Also,
after TUNEL reaction, no cells were labeled at
any time-point of the study. In contrast, consistent
numbers of caspase-3-immunoreactive cells and of
neurons stained with TUNEL were present in the cere-
bella of newborn x-ray irradiated rats, killed 6 hours
later, which were used as positive controls (data not
shown).
Synaptic contacts between parallel fibers and
Purkinje cells
By triple-labeling immunofluorescence and con-
focal microscopy for calbindin, calretinin, and the
vesicular glutamate transporter VGluT1, a presynap-
tic marker of parallel fibers, calretinin-immunoreactive
dystrophic neurites surrounding A deposits in
AβPP/PS1 mice aged 18/20 months were stained
with anti-VGluT1 antibodies, thus confirming that
dystrophic neurites derived from parallel fibers
(Fig. 7a–c). Moreover, the 37-plane 3 m thick
z-stack reconstruction of the confocal images and
the cytofluorogram (Fig. 7d, e) showed a significant
reduction of co-localization of calbindin with VGluT1
(calbindin versus VGluT1, −75%, p < 0.01; VGluT1
versus calbindin, −60%, p < 0.05f) in AβPP/PS1 mice,
suggesting loss of synaptic contacts between Purkinje
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Fig. 8. Parvalbumin immunoreactivity stains Purkinje cells and local-circuit neurons of the molecular layer in normal cerebellum (a). Similar
staining occurs in AβPP/PS1 transgenic mice. However, focal loss of Purkinje cells and local-circuit neurons may occur in transgenic mice
aged 18/20 months. In less affected areas, double-labeling immunofluorescence discloses focal reduction of basket plexuses, as revealed with
antibody RT97 (red), surrounding Purkinje cells, as visualized with anti-calbindin antibodies (green) in transgenic mice (d) when compared
with age-matched WT (c). ML = molecular layer, Pc = Purkinje cell layer, IGL = granule cell layer.
cells and parallel fibers in AβPP/PS1 mice at the age
of 18/20 months.
Basket neurons
Parvalbumin immunoreactivity was used to detect
Purkinje cells and interneurons of the molecular
layer. Dystrophic neurites were not stained with anti-
parvalbumin antibodies. Not only Purkinje cells (as
already noted) but also local-circuit neurons were lost
or unstained in AβPP/PS1 transgenic mice aged 18/20
months (Fig. 8b) when compared with WT (Fig. 8a).
The consequences were best illustrated by double-
labeling immunofluorescence to calbindin and RT97,
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Fig. 9. Double-labeling immunofluorescence and confocal microscope to A (a, d, g, green) and VDAC (b, red), calretinin (e, red) and VGluT1
(h, blue) in the molecular layer of the cerebellum of mice aged 12 months. Dystrophic neurites are seen surrounding A deposits.
which decorates the axons of basket cells, showing
reduced baskets around apparently preserved Purkinje
cells in AβPP/PS1 transgenic mice (Fig. 8d) when
compared to controls (Fig. 8c).
Dystrophic neurites with disease progression in
AβPP/PS1 mice
Similar studies were carried out in AβPP/PS1 mice
aged 12 months. Most A deposits were devoid of
dystrophic neurites, and, therefore, their morphol-
ogy was reminiscent of diffuse plaques. However,
some A deposits were surrounded by dystrophic
neurites. Double-labeling immunofluorescence and
confocal microscopy disclosed altered neurites
filled with VDAC (Fig. 9a) indicating accumula-
tion of mitochondria, and increased expression of
calretinin-immunoreactive granules (Fig. 9b) and
weak enhancement in the expression of VGluT1
(Fig. 9c), thus revealing their origin in parallel fibers.
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Fig. 10. FAD human cerebellum immunostained with anti-synaptophysin antibodies (A, B), and processed for double-labeling immunohisto-
chemistry to A (dark blue) and VDAC (brown) (E, F). v: blood vessel, gr: granular layer. Arrows point to the crown of dystrophic neurites.
A is found in the blood vessel walls and in neuritic plaques.
Neuritic plaques in the cerebellum of FAD
For comparative purposes, paraffin sections of
the cerebellar vermis of sAD and FAD cases were
examined for immunohistochemistry. Unfortunately,
calretinin and VGluT1 antibodies did not work
properly in human cases. However single- and double-
labeling immunohistochemistry to synaptophysin,
VDAC and A disclosed enhanced synaptophysin and
VDAC immunoreactivity around A plaques in FAD
(Fig. 10). No similar alterations were found in relation
with diffuse A plaques in sAD (data not shown).
DISCUSSION
Motor function was evaluated in AβPP/PS1 and WT
mice by using two common tests, the wire hanging
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test and the rotarod, which demonstrate altered motor
performance. It may be argued that the observations
made using these methods are indicative of poor motor
function that may result from causes other than cere-
bellar impairment, such as reduced motor strength
and altered basal ganglia motor coordination. More
specific methods could have been employed but mor-
phological examination of the cerebellum promptly
served to focus the study on the objective visualization
of altered neurons and damaged intrinsic cerebellar
pathways.
The present observations have shown increased A
deposition with disease progression in the cerebellar
cortex of AβPP/PS1 mice. A plaques without dys-
trophic neurites were predominant in mice aged 12
months although a small percentage of A deposits
showed incipient dystrophic neurites at this age. Cere-
bellar A deposits at advanced stages are reminiscent
of A neuritic plaques in the cerebral cortex and
other brain regions in AβPP/PS1 mice [14], and they
are similar to those seen in the cerebellum in FAD
[12]. Dystrophic neurites of A plaques in the cere-
bellum of AβPP/PS1 mice contain phospho-tau and
several proteins including -synuclein, synaptophysin
and ubiquitin, and they are filled with abnormal mito-
chondria and autophagic inclusions, as are plaques of
the cerebral cortex and other regions [14, 16]. This is an
important point, as dystrophic neurites are a fair mani-
festation of altered, non-functional neuronal processes
associated with A deposits.
Cell composition and connectivity of the cerebellar
cortex is well established [22–25]. Briefly, major affer-
ents are the mossy fibers and climbing fibers. Mossy
fibers establish excitatory synapses with dendrites of
granule cells in the glomeruli; climbing fibers pro-
mote excitatory impulses in the proximal dendrites of
Purkinje cells, type II Golgi cells, stellate cells, and
basket neurons. Granule cells throughout the ascend-
ing axons, divided into parallel fibers in the molecular
layer, form excitatory contacts with spines of den-
dritic arbors of Purkinje cells. The system is modulated
by distinct types of local neurons covering type II
Golgi cells in the granular layer which make inhibitory
synapses at granule cell dendrite, and mossy fibers
at the glomeruli; stellate cells in the molecular layer
which are inhibitory of Purkinje cells at the dendritic
arbors; and basket cells, just above the Purkinje cell
layer, whose axons embrace the cell body of Purkinje
cells and provide robust inhibition of these cells. Purk-
inje cells are inhibitory and are the only efferents of
the cerebellar cortex to the deep cerebellar nuclei and
vestibular nuclei.
The present observations have shown degeneration
of parallel fibers associated with A plaques in the
molecular layer as revealed by calretinin staining and
further supported by the expression of the vesicular
glutamate transporter 1 (VGluT1), as a marker of par-
allel fibers [26]. This is associated with reduced focal
synaptic contacts of parallel fibers to Purkinje cells, as
shown by combined cytofluorograms. The toxic effect
of A on parallel fibers is further demonstrated by
the observation of local over-expression of pentraxin 1
(NP1) which is associated with neuronal degeneration
in AD [20], and eventual cell death under particular
conditions [15]. Whether loss of parallel fibers results
in the retrograde degeneration of individual granule
cells, as evidenced with electron microscopy, remains
to be determined, but appears likely.
In addition, other cells are altered without appar-
ent direct contact with A deposition. This was seen
by using antibodies against calbindin and parvalbumin
as markers of Purkinje cells and other local cortical
cerebellar neurons [27, 28]. Quantitative studies have
shown a 25% decrease of Purkinje cells in AβPP/PS1
mice aged 18/20 months. In addition, abnormalities
of Purkinje cells include changes of dendritic arbors
in the molecular layer, axonal torpedoes, increased
axon collaterals, and, importantly, the presence of large
mitochondria mainly in the dendritic arbors, even at
the thin terminal branchlets. Similar mitochondrial
changes are not seen in normal Purkinje cells [24].
Focal loss of basket cells is shown by focal loss
of parvalbumin-immunoreactive cells just above the
Purkinje cell layer and by the reduced number of bas-
ket terminals around the soma of groups of Purkinje
cells.
Since loss of Purkinje cells and axonal torpedoes,
and loss of basket cells, is not physically related to A
plaques, it can be suggested that they are the conse-
quence of other factors rather than of the presence of
plaques. In this line, several studies have shown that
soluble A oligomers are causative of neurodegenera-
tion [29–34], and that maintenance of A oligomers
does not impair disease progression in spite of A
plaque depletion [35].
Increased soluble A has been demonstrated in
the cerebral cortex of AβPP/PS1 mice [14, 36], and the
level of A42 is higher than the level of A40 in the
frontal cortex, hippocampus, and cerebellum in these
mice [36].
Furthermore, intracellular APP and A are
observed in AD under appropriate staining conditions
[37]. Microdissected human neurons analyzed by a
sensitive ELISA have shown increased intracellular
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Fig. 11. Diagram showing the changes in cerebellar cortex circuitry in AβPP/PS1 mice compared with wild type animals (WT). 1) Degeneration
of parallel fibers (PF) in association with A plaques (BA) in the molecular layer; 2) Focal loss of excitatory synaptic contacts following damage
to parallel fibers on dendritic spines of Purkinje cells (Pc), and probably also on Golgi neurons (G), stellate (S) and basket (B); 3) Loss of granule
cells presumably secondary to damage of parallel fibers; 4) Focal loss of basket cells and loss of basket terminals around Purkinje cells may
account for decreased Purkinje cell inhibition; 5) Focal degeneration of Purkinje cells, altered dendritic arbors, axonal swellings (torpedoes)
and increased collateral plexus, probably resulting in reduced cortical inputs to the deep cerebellar nuclei.
levels of A42 in pyramidal neurons and Purkinje cells
in AD when compared with corresponding neurons
in age-matched controls [38]. Therefore, although not
specifically examined in the present study, it can be
assumed that both extracellular soluble and intracellu-
lar A are putatively harmful to cerebellar neurons in
APP/PS1 mice. Whether a link exists between puta-
tive intracellular A and abnormal mitochondria in
Purkinje cells in APP/PS1 mice should be examined
by using suitable experimental paradigms.
As shown in Fig. 11, morphological cerebellar
abnormalities in AβPP/PS1 transgenic mice can be
enumerated as follows: i) loss of parallel fibers in asso-
ciation with A plaques; ii) loss of synaptic contacts
of granule cells to Purkinje cells as a result of focal
degeneration of parallel fibers; iii) focal loss of granule
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cells probably resulting from retrograde degeneration
of parallel fibers; iv) focal loss of baskets probably
leading to focal impairment of Purkinje cell inhibition;
and v) axonal torpedoes, increased axon collaterals,
and focal loss of Purkinje cells probably resulting in
reduced cortical cerebellar outputs. Motor impairment
is not uncommon at advanced stages of FAD due to
PS1 mutations. Spastic paraparesis and parkinsonism
have been observed in several families [39–43]. Cere-
bellar symptoms occur in some pedigrees [43] and are
marked in others [10, 12]. Although the majority of
FAD cases with cerebellar involvement are associated
with PS1 mutations, rare mutations in AβPP are man-
ifested with generalized cerebellar A deposition [9].
On the other hand, transgenic mice with PS1 mutations
alone have not shown clear AD pathology so far. There-
fore, it is difficult at this moment to attribute to APP or
to PS1 mutations their impact on the cerebellar damage
in AβPP/PS1 mice.
The present findings in AβPP/PS1 mice, together
with previous observations showing axonal degenera-
tion in the spinal cord [44], may help to increase our
understanding of motor and cerebellar impairment in
certain advanced FAD cases manifested with motor
and cerebellar symptoms with Purkinje cell loss and
abundant A neuritic plaques.
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M, Fernández-Yagüe N, Moreno J, Juvé S, Pujol A, Pam-
plona R, Portero-Otin M, Martı́n V, Dı́az M, Ferrer I
(2011) Amyloid generation and dysfunctional immuno-
proteasome activation with disease progression in animal
model of familial Alzheimer disease. Brain Pathol, doi:
10.1111/j.1750-3639.2011.00560.x.
[15] Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B,
Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer
TA, Langui D, Duyckaerts C, Tremp G, Pradier L (2003) Time
sequence of maturation of dystrophic neurites associated with
Abeta deposits in AP/PS1 transgenic mice. Exp Neurol 184,
247-263.
[16] Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V,
Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR
(2005) Episodic-like memory deficits in the APPswe/PS1dE9
mouse model of Alzheimer’s disease: Relationships to
300 S. Lomoio et al. / Cerebellar Amyloid-β Plaques
-amyloid deposition and neurotransmitter abnormalities.
Neurobiol Dis 18, 602-617.
[17] Pera M, Alcolea D, Sánchez-Valle R, Guardia-Laguarta C,
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